Encorafenib(Braftovi)

Another NameBraftovi,LuciEncor,康奈非尼

IndicationsIt is indicated for the treatment of unresectable or metastatic melanoma, colorectal cancer and non-small cell lung cancer with BRAF V600E or V600K mutations.